Literature DB >> 2042397

Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arenavirus gene products.

J C Clegg1, S M Wilson, J D Oram.   

Abstract

The nucleotide sequence of the small (S) genomic RNA of Lassa virus (strain GA391, of Nigerian origin) has been determined. The RNA has features which conform to those seen in most other arenavirus S RNAs which have been characterised, including conserved terminal sequences, an ambisense arrangement of the coding regions for the precursor glycoprotein (GPC) and nucleocapsid (N) proteins and an intergenic region capable of forming a base-paired "hairpin" structure. Comparison of the nucleotide sequence with that of the Josiah strain of Lassa virus (from Sierra Leone) reveals considerable nucleotide divergence in the third base of codons in the reading frames of all three proteins, although the resulting protein sequences are highly conserved, with 92, 94 and 91% identical residues for the mature glycoproteins G1 and G2 and the N protein, respectively. Sequence alignments of the available arenavirus structural proteins and dendrograms summarising the relationships between the viral proteins are presented.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2042397     DOI: 10.1016/0168-1702(91)90015-n

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  23 in total

1.  Identification of a novel consensus sequence at the cleavage site of the Lassa virus glycoprotein.

Authors:  O Lenz; J ter Meulen; H Feldmann; H D Klenk; W Garten
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Mutagenesis-induced, large fitness variations with an invariant arenavirus consensus genomic nucleotide sequence.

Authors:  Ana Grande-Pérez; Gema Gómez-Mariano; Pedro R Lowenstein; Esteban Domingo
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-01-25       Impact factor: 16.971

4.  Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates.

Authors:  Igor S Lukashevich; Ricardo Carrion; Maria S Salvato; Keith Mansfield; Kathleen Brasky; Juan Zapata; Cristiana Cairo; Marco Goicochea; Gia E Hoosien; Anysha Ticer; Joseph Bryant; Harry Davis; Rasha Hammamieh; Maria Mayda; Marti Jett; Jean Patterson
Journal:  Vaccine       Date:  2008-08-08       Impact factor: 3.641

5.  A Proteomics Survey of Junín Virus Interactions with Human Proteins Reveals Host Factors Required for Arenavirus Replication.

Authors:  Christopher M Ziegler; Philip Eisenhauer; Jamie A Kelly; Loan N Dang; Vedran Beganovic; Emily A Bruce; Benjamin R King; David J Shirley; Marion E Weir; Bryan A Ballif; Jason Botten
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

6.  Arenavirus phylogeny: a new insight.

Authors:  C G Albariño; D M Posik; P D Ghiringhelli; M E Lozano; V Romanowski
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

Review 7.  The search for animal models for Lassa fever vaccine development.

Authors:  Igor S Lukashevich
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

8.  Imported lassa fever in Germany: molecular characterization of a new lassa virus strain.

Authors:  S Günther; P Emmerich; T Laue; O Kühle; M Asper; A Jung; T Grewing; J ter Meulen; H Schmitz
Journal:  Emerg Infect Dis       Date:  2000 Sep-Oct       Impact factor: 6.883

9.  Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa.

Authors:  Thomas Briese; Janusz T Paweska; Laura K McMullan; Stephen K Hutchison; Craig Street; Gustavo Palacios; Marina L Khristova; Jacqueline Weyer; Robert Swanepoel; Michael Egholm; Stuart T Nichol; W Ian Lipkin
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

10.  Nosocomial outbreak of novel arenavirus infection, southern Africa.

Authors:  Janusz T Paweska; Nivesh H Sewlall; Thomas G Ksiazek; Lucille H Blumberg; Martin J Hale; W Ian Lipkin; Jacqueline Weyer; Stuart T Nichol; Pierre E Rollin; Laura K McMullan; Christopher D Paddock; Thomas Briese; Joy Mnyaluza; Thu-Ha Dinh; Victor Mukonka; Pamela Ching; Adriano Duse; Guy Richards; Gillian de Jong; Cheryl Cohen; Bridget Ikalafeng; Charles Mugero; Chika Asomugha; Mirriam M Malotle; Dorothy M Nteo; Eunice Misiani; Robert Swanepoel; Sherif R Zaki
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.